India link in fresh US insider trading scam
- Mann Ki Baat: Every life lost in Kashmir is a loss to our nation, says PM Narendra Modi
- Our collective mistakes, mishandling, have pushed Kashmir youth to violence: Omar Abdullah
- Kashmir violence: 'Alternative' to pellets already in use, says CRPF affidavit
- ISRO successfully test launches scramjet engine from Sriharikota
- Sri Lanka: Still Counting the Wounds
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
- Dalits are angry about the hollowness of the current hyper-nationalism
- Atal Bihari Vajpayee’s slogan of 'insaniyat, Kashmiriat' has no meaning today
- Kejriwal’s attention is fixed on winning the Centre rather than making mohallas run better
- Inside Track: Turf tussle
- In Kashmir, so-called solutions are riddled with contradictions and divisions
- Why personal, social and political self-identification of Dalits must count more than legal nomenclature.